nausea and vomiting. Nausea and vomiting
Conditions
Interventions
Intervention 1: Intervention group: In the ondansetron group, after expressing nausea and vomiting, individuals will be given 8 milligrams of ondansetron. Intervention 2: Intervention group: In the me
Sponsors
Artesh University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: The patient reports nausea and vomiting after endoscopy. The patient's age must be between 18 and 80 years.
Exclusion criteria
Exclusion criteria: History of allergy to ondansetron or metoclopramide History of other severe drug allergies History of certain medical conditions that could interfere with the results of the study. Patients with gastrointestinal motility disorders (achalasia or lower esophageal sphincter disorder, etc.) Patients with a BMI greater than 45
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The degree of nausea. Timepoint: Until discharge from recovery. Method of measurement: VAS criterion.;Number of times patient vomits after taking the medication. Timepoint: Until discharge from recovery. Method of measurement: Clinical Examination.;Recovery time. Timepoint: Until discharge from recovery. Method of measurement: by the hour. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohamadreza Rafiei
Artesh University of Medical Sciences
Outcome results
None listed